Cargando…
Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin
The ABCG2 transporter protein, as part of several known mechanisms involved in multidrug resistance, has the ability to transport a broad spectrum of substrates out of the cell and is, therefore, considered as a potential target to improve cancer therapies or as an approach to combat drug resistance...
Autores principales: | Paskas, Svetlana, Stockmann, Philipp, Mijatović, Sanja, Kuhnert, Lydia, Honscha, Walther, Hey-Hawkins, Evamarie, Maksimović-Ivanić, Danijela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674596/ https://www.ncbi.nlm.nih.gov/pubmed/38004447 http://dx.doi.org/10.3390/ph16111582 |
Ejemplares similares
-
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo
por: Paskaš, Svetlana, et al.
Publicado: (2022) -
Borcalein: a Carborane‐Based Analogue of Baicalein with 12‐Lipoxygenase‐Independent Toxicity
por: Kuhnert, Robert, et al.
Publicado: (2021) -
The More the Better—Investigation of Polymethoxylated N-Carboranyl Quinazolines as Novel Hybrid Breast Cancer Resistance Protein Inhibitors
por: Stockmann, Philipp, et al.
Publicado: (2023) -
Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs
por: Braun, Sebastian, et al.
Publicado: (2023) -
Carboranyl Analogues of Ketoprofen with Cytostatic
Activity against Human Melanoma and Colon Cancer Cell Lines
por: Buzharevski, Antonio, et al.
Publicado: (2019)